These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17949927)

  • 1. Direct inhibition of CDK9 blocks HIV-1 replication without preventing T-cell activation in primary human peripheral blood lymphocytes.
    Salerno D; Hasham MG; Marshall R; Garriga J; Tsygankov AY; Graña X
    Gene; 2007 Dec; 405(1-2):65-78. PubMed ID: 17949927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDK9 inhibition strategy defines distinct sets of target genes.
    Garriga J; Graña X
    BMC Res Notes; 2014 May; 7():301. PubMed ID: 24886624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective control of gene expression by CDK9 in human cells.
    Garriga J; Xie H; Obradovic Z; Graña X
    J Cell Physiol; 2010 Jan; 222(1):200-8. PubMed ID: 19780058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of cyclin T1/CDK9 complexes during T cell activation.
    Garriga J; Peng J; Parreño M; Price DH; Henderson EE; Graña X
    Oncogene; 1998 Dec; 17(24):3093-102. PubMed ID: 9872325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenyl-1-Pyridin-2yl-ethanone-based iron chelators increase IκB-α expression, modulate CDK2 and CDK9 activities, and inhibit HIV-1 transcription.
    Kumari N; Iordanskiy S; Kovalskyy D; Breuer D; Niu X; Lin X; Xu M; Gavrilenko K; Kashanchi F; Dhawan S; Nekhai S
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6558-71. PubMed ID: 25155598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flavopiridol inhibits P-TEFb and blocks HIV-1 replication.
    Chao SH; Fujinaga K; Marion JE; Taube R; Sausville EA; Senderowicz AM; Peterlin BM; Price DH
    J Biol Chem; 2000 Sep; 275(37):28345-8. PubMed ID: 10906320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HIV-1 replication by P-TEFb inhibitors DRB, seliciclib and flavopiridol correlates with release of free P-TEFb from the large, inactive form of the complex.
    Biglione S; Byers SA; Price JP; Nguyen VT; Bensaude O; Price DH; Maury W
    Retrovirology; 2007 Jul; 4():47. PubMed ID: 17625008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1).
    Chiu YL; Cao H; Jacque JM; Stevenson M; Rana TM
    J Virol; 2004 Mar; 78(5):2517-29. PubMed ID: 14963154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cdk9 during herpes simplex virus 1 infection impedes viral transcription.
    Ou M; Sandri-Goldin RM
    PLoS One; 2013; 8(10):e79007. PubMed ID: 24205359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of HIV-1 transcription at 3% versus 21% oxygen concentration.
    Charles S; Ammosova T; Cardenas J; Foster A; Rotimi J; Jerebtsova M; Ayodeji AA; Niu X; Ray PE; Gordeuk VR; Kashanchi F; Nekhai S
    J Cell Physiol; 2009 Nov; 221(2):469-79. PubMed ID: 19626680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms controlling CDK9 activity.
    Marshall RM; Grana X
    Front Biosci; 2006 Sep; 11():2598-613. PubMed ID: 16720337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation.
    Mbonye U; Wang B; Gokulrangan G; Shi W; Yang S; Karn J
    J Biol Chem; 2018 Jun; 293(26):10009-10025. PubMed ID: 29743242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription.
    O'Keeffe B; Fong Y; Chen D; Zhou S; Zhou Q
    J Biol Chem; 2000 Jan; 275(1):279-87. PubMed ID: 10617616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex effects of flavopiridol on the expression of primary response genes.
    Keskin H; Garriga J; Georlette D; Graña X
    Cell Div; 2012 Mar; 7():11. PubMed ID: 22458775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylation of conserved lysines in the catalytic core of cyclin-dependent kinase 9 inhibits kinase activity and regulates transcription.
    Sabò A; Lusic M; Cereseto A; Giacca M
    Mol Cell Biol; 2008 Apr; 28(7):2201-12. PubMed ID: 18250157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indirubin-3'-monoxime, a derivative of a Chinese antileukemia medicine, inhibits P-TEFb function and HIV-1 replication.
    Heredia A; Davis C; Bamba D; Le N; Gwarzo MY; Sadowska M; Gallo RC; Redfield RR
    AIDS; 2005 Dec; 19(18):2087-95. PubMed ID: 16284457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDK9 a potential target for drug development.
    Canduri F; Perez PC; Caceres RA; de Azevedo WF
    Med Chem; 2008 May; 4(3):210-8. PubMed ID: 18473913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin K inhibits HIV-1 gene expression and replication by interfering with cyclin-dependent kinase 9 (CDK9)-cyclin T1 interaction in Nef-dependent manner.
    Khan SZ; Mitra D
    J Biol Chem; 2011 Jul; 286(26):22943-54. PubMed ID: 21555514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functionally active cyclin-dependent kinase 9 is essential for porcine reproductive and respiratory syndrome virus subgenomic RNA synthesis.
    Wang MD; Yang L; Meng JJ; Pan JJ; Zhang C; Wan B; Sun Y; Wang J; Chu BB; Zhang GP
    Mol Immunol; 2021 Jul; 135():351-364. PubMed ID: 33990004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell lines.
    Herrmann CH; Carroll RG; Wei P; Jones KA; Rice AP
    J Virol; 1998 Dec; 72(12):9881-8. PubMed ID: 9811724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.